Dr. Michael F. Gensheimer, MD

Dr. Gensheimer practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Gensheimer's NPI, 1407172687, was assigned on April 14, 2010. Dr. Gensheimer graduated from Vanderbilt University School Of Medicine in 2010. Dr. Gensheimer holds California license 134180.

Dr. Gensheimer's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Gensheimer's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Gensheimer is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Gensheimer to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Gensheimer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gensheimer practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gensheimer's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gensheimer is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Gensheimer's licenses on file in 2 states: California and Washington.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Gensheimer treats.

CMS data shows 1,188 Medicare services from Dr. Gensheimer across 17 procedure codes in 2024, for 189 Medicare patients. Medicare paid $98,829 for them.

CMS counts 189 Medicare patients who saw Dr. Gensheimer in 2024. The largest group is 65 to 74, with 81 patients. 72% of them have high cholesterol, and 65% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gensheimer's median patient age at 68, with 30% women.

In 2024, Dr. Gensheimer wrote 51 Medicare Part D claims for 27 patients. 92% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $149 in total drug cost. In 2023, CMS named 45 claims across 2 drugs.

Dr. Gensheimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gensheimer as offering telehealth.

Dmand AI links 101 papers to Dr. Gensheimer, published from 2004 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Lung Neoplasms, Radiosurgery and Radiotherapy Dosage. Dr. Gensheimer has published most often in Int J Radiat Oncol Biol Phys. Dr. Gensheimer's most frequent co-authors are Billy W. Loo, MD, PhD, Maximilian Diehn, MD, PhD and Quynh-Thu Xuan Le, MD.

Dmand AI links Dr. Gensheimer to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis and Carcinoma, Bronchogenic.

CMS Open Payments shows 1 general payment to Dr. Gensheimer from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Varian Medical Systems, Inc. paid the most, $97.

Dr. Gensheimer graduated from Vanderbilt University School Of Medicine in 2010.

Dr. Gensheimer is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. EPO plans come from the most carriers, 3. Check the plan with the practice before a visit.